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[~  Survival and physical capacity among lung transplanted 
CF patients in Lund 
L. Lamlefors, K. Heimburg, L. Mared, L. Eriksson. Dept Resp Med, Lund University Hospital, 
Lund, Sweden 
Lung transplantation (LTx) is an established treatment in end-stage pulmonary disease. We have 
performed LTx in CF pats since 1992. The stains of the recipients i reviewed. 
Method: Data was collected from the frequent compulsory check ups, which include lung function 
and 6-minute walk tests. 
Results: 23 CF pats (median and mean age 29 yrs, 1946) have had LTx. Median pre-transplant (tpl) 
FEV1%pred was 20%. One died from malignancy 7 months post-op, one was re-tpl after 3 yrs 
because of obliterative bronchiolitis and is still alive, one had a single LTx. Of those 12 transplanted 
>5 years ago, 11 are still alive. Data for all alive 20 double sequential LTx clue to CF and the selected 
subgroup of those tpl >5 yrs ago are presented below. Median TLC at latest check up was 89% pred. 
Kaplan-Meier curves how 1 and 5 yr survival of 95 and 89% respectively. BOS3 is seen in two pats 
tp112 and 4 yrs ago, BOS2 in one tpl 7 yrs ago. 
Time to best Best (%pted and metres) 
result (yt~) FEV 1 VC 6 / wa lk  
All dbl LTx alive, n = 20 median 3.1 97 95 622 
mean 3.2 95 94 620 
Transplanted >5 yt~ ago, n = 11 median 3.8 95 99 622 
mean 4.3 94 96 625 
Time since Latest (% of  best) 
tpl (yt~) FEV 1 VC 6 / wa lk  
All dbl LTx alive, n = 20 median 5.5 97 1 O0 99 
5.4 86 95 97 lr~ all 
Transplanted >5 yt~ ago, n = 11 median 7.5 92 97 98 
mean 8.5 82 92 98 
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1~ Cystic Fibrosis and ciliary dyskinesia 
D.M. Gonzfilez 1, I. Largo 2. 1HosTital de Cunco, Cunco; 2Universidad e Chile, 
Santiago de Chile, Chile 
Male patient, age 8 years and 6 month, since the age of four months with 
repetitive obstructive bronchitis, bronchopneumonia, otitis and sinusitis, since the 
first year malnutrition with diarrhoea. In 2001 two biopsies were positive for Ciliary 
Dyskinesia with 65% and 80% of altered cilia. The Cystic Fibrosis study showed 
negative sweet test, Sodium 16.9 meq/lt, Chloride 12.5 meq/lt; repetitive positive 
acid steatocrits, prothrombin low 50%; negatives Ig G and IgA for antiendomysium 
and antigliadin antibodies. 
In January 2004, the study for 965 mutations for Cystic Fibrosis was positive for 
two mutations: L997F/F834L and 7T/7T. Since January 2004, he has had only 
one infection for Pseudomonas aeruginosa and repetitive bronchial infections for 
Staphylococcus aureus. At January 2004 he began with a complete treatment for 
Cystic Fibrosis. 
Currently, he is at BMI 50%; negatives bronchial specimens or occasionally 
Staphylococcus aureus. He have never been infected again with Pseudomonas 
aeruginosa; FVC 120%, FEV1 119%, FEF 25 75 111%, pulmonary CT scan with 
few peribrochial thickness, paranasal sinus CT scan with mucosal thickness in all 
the sinus but with right maxillary sinusitis. All the biochemical parameters are 
normal, negatives steatocrits, and prothrombin in 70%. 
Diagnosis: Cystic Fibrosis; Primary Ciliary Dyskinesia 
Conclusion: Survival rate is good, perhaps clue to the pats being a young but not too young disciplined 
group with no B cepacia, brought up to cooperate ina health care team, physically active with a good 
body knowledge and trained to good physical capacity although bad lung function pre-lransplant. And, 
the tpl- and CF-centers work closely together. Pats kept improving their lung function for around 4yrs 
post-tpl. Today, mean 8.5 yrs (5 14) post-tpl, the group tpl >5yrs ago have 92 97% left of their best 
post-tpl lung function and 98% of physical capacity. 
